Literature DB >> 22447521

The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats.

Cassandra O Subiah1, Musa V Mabandla, Alisa Phulukdaree, Anil A Chuturgoon, Willie M U Daniels.   

Abstract

Methamphetamine is a highly addictive stimulant drug whose illicit use and resultant addiction has become an alarming global phenomenon. The mesolimbic dopaminergic pathway has been shown to be fundamental to the establishment of addictive behaviour. This pathway, as part of the reward system of the brain, has also been shown to be important in classical conditioning, which is a learnt response. Within the modulation of learning and memory, the neurohypophyseal hormones vasopressin and oxytocin have been reported to play a vital role, with vasopressin exerting a long- term facilitatory effect and oxytocin exerting an inhibitory effect. Therefore we adopted a conditioned place preference model to investigate whether vasopressin V1b receptor antagonist SSR 149415 or oxytocin treatment would cause a decrease in the seeking behaviour in a reinstatement paradigm. Behavioural findings indicated that methamphetamine induced a change in the place preference in the majority of our animals. This change in place preference was not seen when vasopressin was administered during the extinction phase. On the other hand the methamphetamine-induced change in place preference was enhanced during the reinstatement phase in the animals that were treated with oxytocin. Striatal dopamine levels were determined, as methamphetamine is known to increase dopamine transmission in this area. Significant changes in dopamine levels were observed in some of our animals. Rats that received both methamphetamine and oxytocin had significantly higher striatal dopamine than those that received oxytocin alone. Western blot analysis for hippocampal cyclic AMP response element binding protein (CREB) was also conducted as a possible indicator of glutamatergic NMDA receptor activity, a pathway that is important for learning and memory. The Western blot analysis showed no changes in hippocampal pCREB expression. Overall our data led us to conclude that methamphetamine treatment can change place preference behaviour in rats and that this change may be partially restored by vasopressin antagonism, but exaggerated by oxytocin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447521     DOI: 10.1007/s11011-012-9297-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  63 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

Review 2.  Regulation of transcription factors by neuronal activity.

Authors:  Anne E West; Eric C Griffith; Michael E Greenberg
Journal:  Nat Rev Neurosci       Date:  2002-12       Impact factor: 34.870

Review 3.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

4.  CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats.

Authors:  M C Moffett; N E Goeders
Journal:  Psychopharmacology (Berl)       Date:  2006-11-21       Impact factor: 4.530

5.  Memory effects of arginine vasopressin (AVP) and [7-9] fragment of its peptide chain in rats.

Authors:  T Klimkiewicz
Journal:  Acta Neurobiol Exp (Wars)       Date:  2001       Impact factor: 1.579

6.  Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat.

Authors:  Dara K Shahrokh; Tie-Yuan Zhang; Josie Diorio; Alain Gratton; Michael J Meaney
Journal:  Endocrinology       Date:  2010-03-12       Impact factor: 4.736

7.  Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.

Authors:  G L Kovács; B Bohus; D H Versteeg; E R de Kloet; D de Wied
Journal:  Brain Res       Date:  1979-10-19       Impact factor: 3.252

8.  The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.

Authors:  Akito Tanoue; Shuji Ito; Kenji Honda; Sayuri Oshikawa; Yoko Kitagawa; Taka-Aki Koshimizu; Toyoki Mori; Gozoh Tsujimoto
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

9.  Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.

Authors:  M M Boccia; S R Kopf; C M Baratti
Journal:  Neurobiol Learn Mem       Date:  1998-03       Impact factor: 2.877

Review 10.  Dopamine-mediated regulation of corticostriatal synaptic plasticity.

Authors:  Paolo Calabresi; Barbara Picconi; Alessandro Tozzi; Massimiliano Di Filippo
Journal:  Trends Neurosci       Date:  2007-03-23       Impact factor: 13.837

View more
  6 in total

Review 1.  Obesity and addiction: neurobiological overlaps.

Authors:  N D Volkow; G-J Wang; D Tomasi; R D Baler
Journal:  Obes Rev       Date:  2012-09-27       Impact factor: 9.213

Review 2.  Methamphetamine and the hypothalamic-pituitary-adrenal axis.

Authors:  Damian G Zuloaga; Jason S Jacobskind; Jason S Jacosbskind; Jacob Raber
Journal:  Front Neurosci       Date:  2015-05-27       Impact factor: 4.677

Review 3.  Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits.

Authors:  Manoranjan S D'Souza
Journal:  Front Psychiatry       Date:  2019-07-24       Impact factor: 4.157

Review 4.  Oxytocin, a Novel Treatment for Methamphetamine Use Disorder.

Authors:  Amber N Edinoff; Elliot Thompson; Chandler E Merriman; Mark R Alvarez; E Saunders Alpaugh; Elyse M Cornett; Kevin S Murnane; Rachel L Kozinn; Mila Shah-Bruce; Adam M Kaye; Alan D Kaye
Journal:  Neurol Int       Date:  2022-01-30

5.  Cognitive bias in rats is not influenced by oxytocin.

Authors:  Molly C McGuire; Keith L Williams; Lisa L M Welling; Jennifer Vonk
Journal:  Front Psychol       Date:  2015-09-02

6.  The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.

Authors:  R K Greene; M Spanos; C Alderman; E Walsh; J Bizzell; M G Mosner; J L Kinard; G D Stuber; T Chandrasekhar; L C Politte; L Sikich; G S Dichter
Journal:  J Neurodev Disord       Date:  2018-03-27       Impact factor: 4.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.